AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
4
Israeli digital health company TailorMed acquired in $250 million deal
5
Intel’s Israeli workers fear another downturn after stock collapse and deadly factory blast
More news

ARC Innovation Center

9 stories about ARC Innovation Center
Avner Halperin Sheba

"We're the first hospital outside the US that gets the latest capabilities of OpenAI"

01.11.26|Amy Shapiro
Sheba Impact CEO and ARC Director Avner Halperin details the hospital's ambitions to implement artificial intelligence across all wards by 2027.
ביל אקמן הוועידה השנתית לחדשנות של מרכז arc ב בית החולים שיבא תל השומר

Bill Ackman predicts AI will help Israel produce a trillion-dollar company, warns democratic socialism threatens the U.S. economy

25.10.26|Sophie Shulman
The Pershing Square billionaire, who has invested close to $100 million in Israel, believes AI will give small, highly skilled teams a competitive edge. In an interview with Calcalist, he discusses his Israeli investments, the risks of political polarization and a $400 million initiative to accelerate medical innovation inspired by his daughter’s recovery.
ביל אקמן מייסד ומנכ"ל פרשינג סקוור קפיטל

Bill Ackman in Israel: "The country could become one of the best economies in the world"

22.10.26|Sophie Shulman
Speaking at Sheba Medical Center’s ARC summit, the Pershing Square founder cited Israel’s concentration of talent as a potential advantage in the age of AI. Ackman also discussed his plans for an AI-native brain research institute following his daughter’s stroke.
מכירת ארק של שיבא

Sheba sells ARC innovation arm to Redesign Health

22.10.26|Sophie Shulman
The deal transfers management of ARC’s global network and the rights to establish new hospital innovation centers to the U.S. healthcare venture builder, while Sheba retains its stakes in portfolio companies.
אבנר הלפרין מנכ״ל שיבא אימפקט ומרכז החדשנות ARC

Innovation in a vacuum: Why AI demands global connectivity

13.01.26|Avner Halperin
"The more we facilitate a continuum of data and insights across medical institutions, the better we can provide patients with care based on global, rather than local, experience," writes Avner Halperin, CEO of Sheba Impact.
מנכ״ל קרן ג׳נרל קטליסט המאנט טנג'יה Hemant Taneja

“Bubbles are good”: General Catalyst’s CEO Hemant Taneja on AI hype and real growth

04.09.25|Sophie Shulman
The CEO of the $27B venture giant says bubbles mobilize capital and talent, even as valuations soar without business validation. Despite war and geopolitical challenges, Taneja insisted during a visit to Israel that the quality of what’s being built in the country is “as good as it ever was.”
Space lab experiment

Israeli scientists send bacteria to space on NASA and SpaceX mission in bid to map disease evolution

31.07.25|CTech
An experiment led by ARC, the innovation arm of Sheba Medical Center, and the hospital’s Infectious Diseases Research Laboratory, will examine how microgravity alters bacterial behavior.
Sheba AI

Sheba Medical Center unveils three new AI centers for hospital care

06.03.25|James Spiro
The AI Center, ‘Project K’, and an AI Academy each mark a significant shift in the integration of AI into modern medicine.
Avner Halperin ARC

“The pendulum will start swinging back toward more funding in the early stages,” predicts ARC Innovation Center

01.01.25|James Spiro, Elihay Vidal
Avner Halperin, Deputy Director of ARC and CEO of Sheba Impact, spoke to CTech as part of its 2025 VC Survey.